--Oppenheimer Adjusts Trevi Therapeutics PT to $24 From $23, Maintains Outperform Rating-March 2024-www.financetom.com

--Oppenheimer Adjusts Trevi Therapeutics PT to $24 From $23, Maintains Outperform Rating

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Oppenheimer Adjusts Trevi Therapeutics PT to $24 From $23, Maintains Outperform Rating

Nov 14, 2025 7:25 AM

09:52 AM EST, 11/14/2025 (MT Newswires) --

Price: 12.04, Change: +0.58, Percent Change: +5.06

Previous page： IndiGo Q3 profit rises over 2-fold: 10 key takeaways Next page： IndiGo to hold EGM today to vote on changes demanded by Rakesh Gangwal

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

IndiGo Q3 profit rises over 2-fold: 10 key takeaways

Jan 28, 2020

InterGlobe Aviation Ltd, which runs budget airline IndiGo, announced its October-December earnings on Monday and surprised many by posting a healthy set of numbers. Anu Sharma reports the 10 key takeaways

IndiGo to hold EGM today to vote on changes demanded by Rakesh Gangwal

Jan 28, 2020

Domestic airline IndiGo will hold hold an extraordinary general meeting EGM) on Wednesday as requested by the company's co-founder Rakesh Gangwal.

Enforcement Directorate summons Edelweiss COO Himanshu Kaji in pulses scam case

Jan 28, 2020

The trouble for the Edelweiss Group doesn’t seem to be over yet, as the Enforcement Directorate (ED) has expedited its...

DGFT blacklists Bharti Airtel, stock down over 4 percent

Jan 28, 2020

Shares of Bharti Airtel on Tuesday fell over 4 percent after the Directorate General of Foreign Trade (DGFT) blacklisted Sunil Mittal's telecom firm and put the company in the denied entity list.